Then the plan will be to broaden the label of B-OM
Post# of 72447
(Total Views: 367)
Posted On: 03/16/2018 10:53:33 PM
Quote:
Then the plan will be to broaden the label of B-OM to cover all Chemo Radiation patients including HSTC - the numbers become unthinkable --- in the US Alone ---- 650,000 people annually in the U.S alone! World Wide?????? Hundreds of Millions. All will have the ability to be prescribed B-OM for prevention.
Woah! I missed something. 650K in the USA and 100M+ worldwide? I would think the USA is more than 0.65% of the chemo/radiation market. Where did you come up with such a large number for outside the USA? I ask because your stuff is usually bullet proof but at $200/patient you just made this a $20B/year drug with your figure.
Go IPIX!
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.